Metraipolis › archive › dc_feb8d1c7cb84
Prediction of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy Using Agile 3+ and End-of-Treatment Alpha-Fetoprotein Levels in Patients With… — Europe PMC PMID:41133105
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41133105
- DOI
- 10.1002/jgh3.70296
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T03:35:22.913Z
- SHA-256 of the archived text
ead641da63bcad3debe74d7542823c571e16769239e158522f912b7e9aa21509- Stable URL of this page
https://metraipolis.com/documento/dc_feb8d1c7cb84
How to cite
Prediction of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy Using Agile 3+ and End-of-Treatment Alpha-Fetoprotein Levels in Patients With… — Europe PMC PMID:41133105 — Europe PMC (en), https://europepmc.org/article/MED/41133105 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_feb8d1c7cb84 (Metraipolis archive dc_feb8d1c7cb84, sha256 ead641da63bcad3debe74d7542823c571e16769239e158522f912b7e9aa21509)
BibTeX
@misc{dcfeb8d1c7cb84,
title = {Prediction of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy Using Agile 3+ and End-of-Treatment Alpha-Fetoprotein Levels in Patients With… — Europe PMC PMID:41133105},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41133105},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_feb8d1c7cb84; sha256 ead641da63bcad3debe74d7542823c571e16769239e158522f912b7e9aa21509},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41133105. Agents can read the archived copy with the MCP tool read_document.